Spectral Medical Inc. (EDT.TO)
CAD 0.72
(5.88%)
CAD 0.72
(5.88%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -11.36 Million | -9.92 Million | -8.7 Million | -324 Thousand | -2.73 Million | -2.32 Million |
| Net Income | -15.5 Million | -11.25 Million | -8.78 Million | -9.09 Million | -4.86 Million | -2.48 Million |
| Depreciation & Amortization | 218 Thousand | 272 Thousand | 294 Thousand | 304 Thousand | 278 Thousand | 230 Thousand |
| Deferred income taxes | -1.34 Million | - | 260 Thousand | 171 Thousand | 64 Thousand | - |
| Stock-based compensation | 1.48 Million | 1.19 Million | 1.25 Million | 880 Thousand | 622 Thousand | 713 Thousand |
| Change in working capital | -406 Thousand | 659 Thousand | -1.75 Million | 7.38 Million | 1.12 Million | -811 Thousand |
| Other non-cash items | 4.19 Million | -806 Thousand | 28 Thousand | 32 Thousand | 36 Thousand | 35 Thousand |
| Investing Cash Flow | -185 Thousand | -33 Thousand | -325 Thousand | -297 Thousand | -161 Thousand | -47 Thousand |
| Investments in PPE | -185 Thousand | -33 Thousand | -483 Thousand | -315 Thousand | -161 Thousand | -47 Thousand |
| Acquisitions | - | - | 158 Thousand | 18 Thousand | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 158 Thousand | 18 Thousand | - | - |
| Financing Cash Flow | 6.08 Million | 9.48 Million | 12.16 Million | 5.18 Million | 23 Thousand | 5.28 Million |
| Debt repayment | -4.05 Million | -91 Thousand | -113 Thousand | -109 Thousand | -105 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 4.02 Million | 10 Million | 5.1 Million | 128 Thousand | 5.3 Million |
| Other Financing Activities | 2.15 Million | 5.55 Million | 2.27 Million | 189 Thousand | 23 Thousand | -20 Thousand |
| Accounts receivables | 870 Thousand | -877 Thousand | 55 Thousand | 11 Thousand | 1.16 Million | -552 Thousand |
| Accounts payables | -267 Thousand | 1.64 Million | -1.1 Million | 1.42 Million | 146 Thousand | -357 Thousand |
| Inventory | -26 Thousand | -47 Thousand | -51 Thousand | -72 Thousand | -79 Thousand | -6000.00 |
| Other working capital | -983 Thousand | -62 Thousand | -656 Thousand | 6.02 Million | -107 Thousand | 104 Thousand |
| Cash at beginning of period | 8.41 Million | 8.89 Million | 5.8 Million | 1.43 Million | 4.36 Million | 1.44 Million |
| Cash at end of period | 2.95 Million | 8.41 Million | 8.89 Million | 5.8 Million | 1.43 Million | 4.36 Million |
| Capital Expenditure | -185 Thousand | -33 Thousand | -483 Thousand | -315 Thousand | -161 Thousand | -47 Thousand |
| Effect of forex changes on cash | - | - | -56 Thousand | -187 Thousand | -57 Thousand | 59 Thousand |
| Net cash flow / Change in cash | -5.46 Million | -476 Thousand | 3.08 Million | 4.37 Million | -2.93 Million | 2.91 Million |
| Free Cash Flow | -11.54 Million | -9.96 Million | -9.18 Million | -639 Thousand | -2.89 Million | -2.36 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -4.4 Million | -4.15 Million | -15.5 Million | -6.52 Million | -3.39 Million | -3.93 Million |
| Depreciation & Amortization | 65 Thousand | 131 Thousand | 218 Thousand | 46 Thousand | 56 Thousand | 49 Thousand |
| Deferred income taxes | - | - | -1.34 Million | 1.17 Million | 180 Thousand | -67 Thousand |
| Stock-based compensation | 1.07 Million | 177 Thousand | 1.48 Million | 188 Thousand | 339 Thousand | 987 Thousand |
| Change in working capital | 550 Thousand | 778 Thousand | -406 Thousand | 1.75 Million | -653 Thousand | 465 Thousand |
| Other non-cash items | -313 Thousand | 2.98 Million | 4.19 Million | 1.69 Million | 234 Thousand | 170 Thousand |
| Investing Cash Flow | -8000.00 | -16 Thousand | -185 Thousand | -185 Thousand | 7000.00 | -7000.00 |
| Investments in PPE | -8000.00 | -16 Thousand | -185 Thousand | -185 Thousand | 7000.00 | -7000.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 9.1 Million | 362 Thousand | 6.08 Million | -238 Thousand | 5.74 Million | -30 Thousand |
| Debt repayment | -8.53 Million | -33 Thousand | -4.05 Million | -2.15 Million | -6.21 Million | -30 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 617 Thousand | 395 Thousand | - | - | - | - |
| Other Financing Activities | -43 Thousand | 395 Thousand | 2.15 Million | 2.04 Million | 11.95 Million | -30 Thousand |
| Accounts receivables | 130 Thousand | -296 Thousand | 870 Thousand | 534 Thousand | 22 Thousand | 362 Thousand |
| Accounts payables | 417 Thousand | -453 Thousand | -267 Thousand | 986 Thousand | -574 Thousand | 470 Thousand |
| Inventory | 47 Thousand | 47 Thousand | -26 Thousand | -62 Thousand | -16 Thousand | 61 Thousand |
| Other working capital | -44 Thousand | 1.48 Million | -983 Thousand | 301 Thousand | -85 Thousand | -428 Thousand |
| Cash at beginning of period | 2.07 Million | 2.95 Million | 8.41 Million | 5.03 Million | 2.52 Million | 4.88 Million |
| Cash at end of period | 7.53 Million | 2.07 Million | 2.95 Million | 2.95 Million | 5.03 Million | 2.52 Million |
| Capital Expenditure | -8000.00 | -16 Thousand | -185 Thousand | -185 Thousand | 7000.00 | -7000.00 |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 5.46 Million | -878 Thousand | -5.46 Million | -2.07 Million | 2.51 Million | -2.36 Million |
| Free Cash Flow | -3.64 Million | -1.24 Million | -11.54 Million | -1.84 Million | -3.22 Million | -2.34 Million |
CCSI
6425
AFX
USCU
AMD
ELUXY